17 insiders reported 19 Form 4 transactions for Avidity Biosciences, Inc. (RNAM) over the past 18 months (most recent 2026-02-27). Recent activity: Kaye Edward M. MD (Director) Sell 6,692 shares, Moriarty John B (Chief Legal Officer) Sell 92,054 shares, BOESS CARSTEN (Director) Sell 6,692 shares, Boyce Sarah (President and CEO) Sell 474,861 shares, Skerjanec Simona (Director) Sell 6,692 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | Kaye Edward M. MD | Director | Sell | 6,692 | $0 |
| 2026-02-27 | Moriarty John B | Chief Legal Officer | Sell | 92,054 | $0 |
| 2026-02-27 | BOESS CARSTEN | Director | Sell | 6,692 | $0 |
| 2026-02-27 | Boyce Sarah | President and CEO | Sell | 474,861 | $0 |
| 2026-02-27 | Skerjanec Simona | Director | Sell | 6,692 | $0 |
| 2026-02-27 | Hughes Steven George | Chief Medical Officer | Sell | 115,857 | $0 |
| 2026-02-27 | McCarthy Teresa | Chief Human Resources Officer | Sell | 165,296 | $0 |
| 2026-02-27 | Gallagher Kathleen P. | Chief Program Officer | Sell | 80,303 | $0 |
| 2026-02-27 | Mosbrooker Eric | Chief Commercial Officer | Sell | 79,413 | $0 |
| 2026-02-27 | Henig Noreen | Director | Sell | 6,692 | $0 |
| 2026-02-27 | WILSON TROY EDWARD | Director | Sell | 65,091 | $0 |
| 2026-02-27 | WILSON TROY EDWARD | Director | Sell | 13,711 | $0 |
| 2026-02-27 | MacLean Michael F | Chief Financial Officer | Sell | 133,977 | $0 |
| 2026-02-27 | Thompson Tamar | Director | Sell | 6,692 | $0 |
| 2026-02-27 | Calderaro Charles III | Chief Technical Officer | Sell | 98,547 | $0 |
| 2026-02-27 | Flanagan W. Michael | Chief Scientific Officer | Sell | 150,365 | $0 |
| 2026-02-27 | Kim Jean Jinsun | Director | Sell | 6,692 | $0 |
| 2026-02-27 | LEVIN ARTHUR A | Director | Sell | 16,562 | $0 |
| 2026-02-27 | LEVIN ARTHUR A | Director | Sell | 131,372 | $0 |
Source: SEC Form 4 filings · as of 2026-02-27
